Current status of clinical development in MM

Multiple myeloma
Preclinical
Phase I
Phase II
Phase III
Approval
ACP - 001Mono therapy study (consolidation)
Completed FIH Phase I/II
ISA-HC-NK​Combination study (consolidation)
Ongoing phase II study